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Background Insecticide-treated mosquito nets (ITNs) and indoor-residual spray-
ing (IRS) are recommended strategies for preventing malaria in
children. While their impact on all-cause child mortality is well
documented, their impact on reducing malaria-attributable mortal-
ity has not been quantified. While the impact of intermittent pre-
ventive therapy in pregnant women (IPTp) and ITNs in pregnancy
for improving birth outcomes is also well established, their impact
on preventing neonatal or child mortality has not been quantified.
Methods We performed two systematic literature reviews in Plasmodium
falciparum endemic settings; one to estimate the effect of ITNs
and IRS on preventing malaria-attributable mortality in children
1–59 months, and another to estimate the effect of ITNs and
IPTp on preventing neonatal and child mortality through improve-
ments in birth outcomes.
Results We estimate the protective efficacy (PE) of ITNs and IRS on redu-
cing malaria-attributable mortality 1–59 months to be 55%, with
a range of 49–61%, in P. falciparum settings. We estimate malaria
prevention interventions in pregnancy (IPTp and ITNs) to have
a pooled PE of 35% (95% confidence interval: 23–45%) on reducing
the prevalence of low birth weight (LBW) in the first or second
pregnancy in areas of stable P. falciparum transmission.
Conclusion This systematic review quantifies the PE of ITNs for reducing
malaria-attributable mortality in children, and the PE of IPTp and
ITNs during pregnancy for reducing LBW. It is assumed the impact
of IRS is equal to that of ITNs on reducing malaria-attributable
mortality in children. These data will be used in the Lives Saved
Tool (LiST) model for estimating the impact of malaria prevention
interventions. These data support the continued scale-up of these
malaria prevention interventions in endemic settings that will
prevent a considerable number of child deaths due directly and
indirectly to malaria.
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Introduction
Approximately 1.38 billion people in the world are
exposed to stable Plasmodium falciparum transmission,
which is the species responsible for most malaria
deaths.
1 The bulk of the burden of malaria mortality
in 2007 occurred among the estimated 108 million
African children exposed to stable P. falciparum trans-
mission.
1 Malaria in sub-Saharan Africa was esti-
mated to have caused over 800000 child deaths in
2000.
2
Fortunately, effective interventions for preventing
malaria mortality in children are available and are
being scaled-up across malaria endemic areas of
Africa. These include insecticide-treated mosquito
nets (ITNs), indoor-residual spraying (IRS) and inter-
mittent preventive therapy in pregnant women
(IPTp). Both ITNs and IRS prevent malaria transmis-
sion by reducing the chances that an individual will
be bitten by an infective Anopheles mosquito. IPTp is
the administration of two or more treatment doses of
an effective antimalarial drug given at defined inter-
vals during pregnancy of at least 1 month, regardless
of whether the woman has a parasite infection at the
time of treatment. It acts as treatment of existing
infections (symptomatic or not) and as prophylaxis
by limiting the development of infection for an inter-
val of time in pregnancy.
ITNs and IRS are recommended strategies for pre-
venting malaria in children with their impact on
all-cause child mortality (ACCM) well demon-
strated.
3–7 Two ITN trials have attempted to assess
the effect of ITNs on mortality due to malaria in
children.
8,9 However, these studies yielded non-
significant results that were inconsistent with reduc-
tions in ACCM, likely because of misclassification bias
from post-mortem verbal autopsies.
10–12 Thus, their
impact on reducing deaths due to malaria in children
has not been well quantified. While IPTp and ITNs for
preventing malaria in pregnancy and improving birth
outcomes is also well established, their impact on
preventing neonatal or child mortality has not been
quantified. We performed systematic literature
reviews to identify individual and community-
randomized controlled trials to estimate the effect of
ITNs and IRS on preventing malaria-attributable mor-
tality, defined here as mortality due directly to
malaria, in children 1–59 months (assuming no
malaria deaths occur during the neonatal period),
and to estimate the effect of ITNs and IPTp on pre-
venting neonatal and child deaths through improve-
ments in birth outcomes, in P. falciparum endemic
settings.
Materials and methods
These reviews of effectives of the interventions are
shaped in large part by the needs of the Lives Saved
Tool (LiST) model. In that model, increases in cover-
age of an intervention results in a reduction of one or
more cause-specific deaths or in reduction of a risk
factor. Therefore, the reviews and the GRADE process
used were designed to develop estimates of the effect
of an intervention in reducing either a risk factor or a
death due to specific cause. For more details of the
review methods, the adapted grade approach or the
LiST model see other articles in this supplement.
To quantify the protective effect of ITNs and IRS
in preventing direct-malaria deaths in children, and
for IPTp and ITNs among pregnant women in pre-
venting neonatal and child deaths through improved
birth outcomes, we conducted a systematic litera-
ture review to identify individual and community-
randomized controlled trials using PUBMED,
WHOLIS, CAB Abstracts via OVID Global Health,
SIGLE and LILAC search engines. An attempt was
made to identify unpublished studies through contact
with experts in the field. Studies were limited to
those implemented in areas of endemic P. falciparum
malaria transmission. Where insufficient data from
individual or community-randomized controlled
trials could be identified, we included quasi-
experimental and observational studies.
Data from studies meeting the inclusion criteria,
as outlined below, were reviewed and data were
abstracted into a standardized dataset. Extracted
data included the following study characteristics:
site, duration, target population, design, intervention
definition, outcome definitions, raw data on outcomes
of interest, study effect with 95% confidence intervals
(CIs) and standard errors for each outcome, and any
noted limitations or biases. The study quality was
assessed according to the GRADE technique adapted
by the Child Health Epidemiology Reference Group.
13
Studies were grouped according to type of study
outcome and study designs for meta-analysis using
STATA 10.0. Meta-analyses are reported as the
Mantel–Haenszel pooled relative risks (RRs) with
accompanying 95% CIs. For community-randomized
controlled trials, the empirically estimated standard
errors as reported in the literature, either directly
or estimated from 95% CIs, were used in the
meta-analysis.
ITNs for children
We sought to measure the effect of ITNs in compar-
ison with no mosquito net on child health outcomes
in P. falciparum malaria endemic settings. To be
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one of the following outcomes among children under
5 years old: malaria-attributable mortality, all-cause
mortality, incidence of severe or uncomplicated
malaria or the prevalence of malaria parasite infec-
tion. Studies assessing the impact of insecticide-
treated barriers for vector controls other than
ITNs, such as insecticide-treated curtains, were
excluded, as the LiST model only includes ITNs.
A comprehensive and thorough Cochrane Review
was performed through 2002 and published in
2004.
3 Relevant data were included from the 2004
Cochrane Review, with our search focused on iden-
tifying eligible studies conducted after the inclusion
dates of the Cochrane Review (post 2002). A combi-
nation of the following search terms was used:
malaria, Plasmodium; bednet, mosquito net, ITN,
LLIN, insecticide-treated, impregnated, permethrin,
lambdacyhalothrin, deltamethrin and cyfulthrin.
Studies that compared ITNs with untreated mosquito
nets were excluded.
IRS
We sought studies that measured the effect of IRS
compared with no spraying on child health outcomes
related to malaria in P. falciparum malaria endemic
settings. To be included in this analysis, IRS trials
had to measure one of the following outcomes among
children under 5 years old: malaria-attributable
mortality, all-cause mortality, incidence of severe or
uncomplicated malaria or the prevalence of malaria
parasite infection. A combination of the following
search terms was used: malaria, Plasmodium, IRS,
insecticide, deltamethrin, Lambda-cyhalothrin, Icon,
dichloro-diphenyl-trichloroethane and Bendiocarb.
Studies that evaluated IRS plus another intervention
(e.g. ITNs), for which the IRS-specific effect could
not be isolated, were excluded.
Prevention of malaria during pregnancy
related to improved birth outcomes
Intermittent preventive therapy in pregnant women
We sought studies that measured the effect of at least
two doses per pregnancy of IPTp with sulphadoxine–
pyrimethamine (SP) vs a placebo on child health out-
comes within P. falciparum malaria endemic settings,
independent of ITNs. For IPTp trials to be included in
this analysis, one of the following outcomes had to be
measured: intrauterine growth retardation (IUGR),
pre-term delivery, prematurity, low birth weight
(LBW), perinatal mortality, neonatal mortality,
infant mortality or child mortality. Two comprehen-
sive reviews have been published with data through
2006.
14,15 In addition to relevant data from the
Cochrane Review meeting the inclusion criteria, a lit-
erature search was conducted limited to studies pub-
lished after 2006. A combination of search terms was
used including: malaria, Plasmodium, sulphadoxine,
pyrimethamine, IPT, IPTp, intermittent preventive
treatment and pregnancy. Trials that compared two
doses of IPTp to another drug (not a placebo) were
excluded, as were trials that assessed IPTp compared
with ITNs where the effect of IPTp against a placebo
could not be isolated.
ITNs for pregnant women
We sought studies that measured the effect of access
to ITNs among pregnant women vs no ITNs on child
health outcomes within P. falciparum malaria endemic
settings, independent of IPTp. For ITN trials to be
included in this analysis, one of the following out-
comes had to be measured: IUGR, pre-term birth,
LBW, perinatal mortality, neonatal mortality, infant
mortality or child mortality. Trials that compared
ITNs with untreated nets were excluded, as were
trials that assessed ITNs plus IPTp where the effect
of ITNs against no mosquito net (placebo) could not
be isolated. As a thorough and comprehensive system-
atic review was recently published with data through
February 2009,
16 we did not attempt to update their
findings but reference those within the review that
met our inclusion/exclusion criteria.
Deriving the impact of ITNs on
malaria-attributable mortality in children
from observed reductions in ACCM
While there are robust data for the protective efficacy
(PE) of ITNs against ACCM among children 1–59
months,
3 no such data are currently available on
their impact of malaria-attributable mortality. It was
therefore necessary to derive an estimate of the PE of
ITNs for reducing malaria-attributable mortality
(PEMAM) from ACCM thusly.
PEMAM ¼
PEACCM

ð1Þ
where PEACCM is equal to the PE (per cent) of ITNs in
reducing ACCM among children aged x, and ß is equal
to an estimate of the per cent of deaths from
all-causes due to malaria among children aged x in
areas without access to malaria prevention interven-
tions. Due to the likelihood of misclassification bias
where ß is estimated from post-mortem verbal
autopsies,
10–12 we present two methods.
The first approach used a pooled estimate of the
PEACCM among children 1–59 months across trials,
represented as PEACCM 1–59m, and an aggregate esti-
mate of ß based on the per cent of all <5 deaths
across 20 countries with stable malaria transmission
in sub-Saharan African in 2000 that were due directly
to malaria, which was estimated to be 22.4% (95% CI
19.8–24.9%), represented here as ß<5.
17 However, it
was then necessary to remove neonatal deaths from
this estimate of ß<5 to get the proportion of all deaths
1–59 months due to malaria, represented by ß1–59m.I t
has previously been estimated that  26% of child
deaths occurred during the first month of life in
sub-Saharan Africa between 2000 and 2003.
18
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tal period, ß1–59m was estimated as the per cent of
malaria deaths <5 (ß<5¼22.4%)/(100–26%) or
30.2%. Using Equation (1), the PE of ITNs on direct
malaria mortality 1–59 months (PEMAM 1–59m)i s
estimated as: the pooled PEACCM 1–59/30.2%.
An alternative disaggregated approach uses esti-
mates of PEACCM 1–59 and ß within each ITN trial
study site rather than using a pooled estimate of the
PEACCM among children 1–59 months across trials
(PEACCM 1–59 m) and an aggregate estimate of ß
under the general premise outlined previously. Using
equation (1), an estimate of PEMAM 1–59m within each
study site is obtained as: PEACCM1–59/ß1–59m. As esti-
mates of ß within each study were obtained from
post-mortem verbal autopsies among all children
<5 years old, ß1–59m was estimated with the removal
of neonatal deaths as outlined above. The resultant
PEDMM 1–59m (%) were then transformed to RRs
(RR¼[(100 PE)/100] and pooled across trials with
a meta-analysis weighted by the inverse standard
error of the RR for ACCM reductions obtained by
each trial.
Results
ITNs for children
The Cochrane Review included 14 studies performed
in stable P. falciparum endemic settings, all of which
were conducted in sub-Saharan Africa. Ten of these
studies included the effect of ITNs vs no nets with
outcomes specific to children
3 (Figure 1), of which
three reported the effect of ITNs on ACCM
8,19,20
(Supplementary Table 1). All of these trials used an
intention-to-treat analysis for assessing the impact of
ITNs on ACCM, where intervention villages were pro-
vided with high household ITN coverage (nearly
100%) and control villages received no ITNs. ITN
use by children in these trials ranged from 50% to
97%, depending on the season. Four studies also
reported the effect of ITNs on the incidence of
uncomplicated malaria,
21–24 while six reported the
effect of ITNs on the prevalence of malaria parasite-
mia
8,20,21,25–27 (Supplementary Table 1). Two trials
that assessed the impact of ITNs on ACCM also
attempted to assess their impact on malaria-
attributable mortality; neither showed significant
results.
8,9 However, both were excluded from the
2004 Cochrane Review because of the likelihood of
misclassification bias from post-mortem verbal autop-
sies that resulted in contradictory results with ACCM,
which is a much more robust outcome measure.
Both are also excluded here.
The systematic review of studies published after
2002 revealed 163 abstracts, of which 24 contained
an outcome of interest. Only two of these studies
were randomized trials, one limited to infants
28 and
one comparing ITNs to untreated nets.
3 Both studies
were therefore excluded. The resulting meta-analyses,
which are largely consistent with the 2004 Cochrane
Review without the inclusion of the trial assessing the
impact of insecticide-treated curtains,
29 show a PE
of ITNs for reducing ACCM 1–59 months¼18%
(RR¼0.82: 95% CI¼0.75–0.90) (Figure 2 and
Table 1). Four trails show a PE of ITNs for reducing
uncomplicated malaria incidence in children by 51%
(RR¼0.49: 95% CI¼0.44–0.54), while six trials show
a PE of ITN for reducing malaria parasite infection
prevalence in children by 17% (RR¼0.83: 95%
CI¼0.64–0.88) (Table 1).
Based on Rule 1,
30 the PE of ITNs on reducing
malaria-attributable mortality should therefore be
derived from high quality evidence of reductions in
ACCM. The first approach, as outlined in the mate-
rials and methods section, using the pooled estimate
of the PEACCM among children 1–59 months across
trials (PEACCM 1–59m¼18%) and the aggregate propor-
tion of all under five deaths due directly to malaria in
Total search results = 186
2004 Cochrane Review = 13
Post Cochran = 163
Studies remaining after screening title and 
abstract = 47
10 studies included for data abstraction
(all community randomized controlled trials; 
all in 2004 Cochrane Review)
All-cause child 
mortality = 3
Incidence of 
uncomplicated malaria 
= 4
Prevalence of malaria 
parasitemia = 6
37 studies excluded due 
to lack of appropriate 
control group or did not 
assess an appropriate 
child health outcome in
P. falciparum endemic 
setting
Figure 1 Results of systematic review on the effect of ITNs on child health outcomes
PREVENTION OF MALARIA IN ENDEMIC AREAS i912000 1–59 months (ß1–59m¼30.2%) yielded an esti-
mate of the PE of ITNs at reducing
malaria-attributable mortality 1–59 months¼60%.
The second approach using the disaggregated
method yielded a pooled PE of ITN at reducing
malaria-attributable mortality 1–59 months¼49%
(Table 2). Our best estimate therefore suggests that
the PE of ITNs on malaria-attributable mortality 1–59
months ranges between 49% and 60%, with the point
estimate for the LiST model being the mid-point of
55% (Box 1).
IRS
The literature review revealed 177 abstracts for IRS, of
which 31 included outcomes of interest among chil-
dren in P. falciparum endemic settings of sub-Saharan
Africa (Figure 3). Seven studies met the inclusion cri-
teria and are included in this analysis: three prior to
1976 and four since 1996 (Table 3).
4–7,31–33 The only
community-randomized controlled trial identified in
the search was excluded because it was among refu-
gees and therefore lacked external validity.
34 Other
studies with desired outcomes were excluded because
they did not represent comparisons of IRS to control
households, but included ITNs and other interven-
tions. Two of the seven studies contained the outcome
of IRS on ACCM,
5,6 three contained all-cause infant
mortality,
5–7 three contained incidence of uncompli-
cated malaria
7,31,32 and five contained the preva-
lence of malaria parasitemia in children
6,31,32,35,36
(Supplementary Table 2).
While showing positive reductions in the malaria
burden, all included studies evaluated the effect of
IRS on child health outcomes using a pre/post-study
design and therefore suffer from serious methodolog-
ical weaknesses which limit internal validity and sub-
sequent interpretation of results vis-a `-vis IRS PE on
malaria-attributable mortality (Table 3). Based on the
fact that IRS impact on malaria morbidity has been
shown to be similar to that of ITNs for which there
are robust empirical data,
37 IRS PE on
malaria-specific mortality in the LiST model will be
set equal to ITNs at 55% as described above.
Prevention of malaria during pregnancy
related to improved birth outcomes
The 2006 Cochrane Review and the 2007 review for
IPTp included four studies performed in areas of
stable P. falciparum transmission which included the
effect of IPTp vs placebo with outcomes specific to
birth outcomes or child health.
14,15 An additional lit-
erature search limited to articles published after the
Cochrane Review (post 2006) revealed 23 abstracts;
the only trial which contained an outcome of interest
was excluded because it assessed the impact of IPTp
þITNs vs ITNs alone, where the effect of IPTp alone
vs a placebo could not be isolated
38 (Figure 4). Of the
studies included here, two contained the outcome of
neonatal mortality,
39,40 one contained perinatal
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40 and three contained the outcome of LBW
prevalence (<2500g)
39,41,42 (Supplementaey Table 3).
All were conducted in sub-Saharan Africa. The
meta-analysis of data available from two randomized
controlled trials shows no evidence of a statistically
significant reduction in neonatal mortality
among women in the first or second pregnancy
(Table 4).
14 The one study that assessed the
impact of IPTp on perinatal mortality was also insig-
nificant among women in the first or second preg-
nancy. Based on two randomized controlled trials,
the 2006 Cochrane Review shows that IPTp, isolated
from ITNs, significantly reduces the prevalence of
LBW with an RR of 0.58 (95% CI: 0.43–0.78) among
pregnant women in their first or second pregnancy.
A more recent review containing three randomized
controlled trials (the two previous trials in the
2006 Cochrane Review plus one additional trial)
within the context of SP resistance and ITNs in
sub-Saharan Africa found IPTp among women in
their first or second pregnancy significantly reduces
the prevalence of LBW with an RR of 0.71 (95%
CI: 0.55–0.92). A meta-analysis limited to studies
without ITNs shows that IPTp reduces the
prevalence of LBW with an RR of 0.64 (95% CI:
0.56–0.72), resulting in IPTp having a PE of 36%
(95% CI: 28–44%) independent of ITNs (data not
shown).
Results from two trials included in the recently pub-
lished 2009 Cochrane Review show access to ITNs,
isolated from IPTp, to reduce LBW with an RR of
0.71 (95% CI: 0.54–0.92), suggesting that ITNs have
RR (95% CI) 
Binka
(Ghana 1996) 
Nevill
(Kilifi Kenya 1996) 
Philips-Howard  
(western Kenya 2003) 
Overall (I
2 = 0%) 
0.82 (0.68 - 0.98) 
0.71 (0.52 - 0.96) 
0.84 (0.75 - 0.94) 
0.82 (0.75 - 0.90) 
  25.5 
    9.0 
  65.5 
100.0
1 .1
Relative Risk (95% Confidence Interval) 
Heterogeneity X
2 = 1.5 (d.f = 2); P-value = 0.473 
I
2 (variance RR attributable to heterogeneity) = 0% 
Test for RR= 1; Z = 4.16; P-value < 0.001  
Study ID  Weight (%)
10
Figure 2 Forest plot for the meta-analysis of the effect of ITNs on reducing ACCM
Table 2 Disaggregated meta-analysis of ITN trials for estimating the PE of ITNs for preventing malaria deaths in children
1–59 months
Study site/study year
RR for all cause
child mortality
1–59 months
(95% CI)
Standard
error of
the RR
PE at reducing
ACCM 1–59
months (%)
(95% CI)
Per cent of
deaths from
all causes due
directly to malaria
(ß)
a (years) Ref.
PE of ITNs
on malaria-
specific
mortality (%)
Ghana (Kassena-Nankana)
1993–95
8
0.82 (0.68–0.98) 0.093 18 41 (1993–95)
8,62 44
Kenya (Kilifi) 1993–95
20 0.71 (0.52–0.96) 0.157 29 46 (1991–93)
62,63 63
Kenya (Asembo/Gem)
1997–99
19
0.84 (0.75–0.94) 0.058 16 36 (1997–98)
19,62 44
Meta-analysis 0.82 (0.75–0.90) 18 (10–25) 49
b
aß in Equation (1): per cent deaths from all causes due to malaria 1–59 months¼per cent deaths from all causes due to malaria
0–59 months/74%; assuming no malaria deaths occur in the neonatal period and that 26% of deaths in children under five occur in
the neonatal period
18.
bRandom effects model; 
2 (2df)¼6.3.
PREVENTION OF MALARIA IN ENDEMIC AREAS i93a PE of 29% (95% CI: 8–46%) among women in the
first or second pregnancy in areas of stable P. falci-
parum transmission, independent of IPTp.
16,41,43 While
the Njagi (2002) study used individual randomization
and the ter Kuile (2003) study used community ran-
domization, both assessed the impact of access to
ITNs based on intention-to-treat, thus individual use
was not assessed. There was no available evidence of
ITNs preventing pre-term deliveries or neonatal
mortality.
As the effects of IPTp and ITNs used during preg-
nancy have similar causal pathways for improving
birth outcomes as measured by LBW, and as there
is no evidence of a synergistic effect between
them,
38 the data were pooled with a meta-analysis
to yield an RR of 0.65 (95% CI: 0.55–0.77) for redu-
cing LBW from either IPTp or ITNs among women in
the first or second pregnancy (Table 4 and Figure 5).
A pooled PE point estimate of 35% is therefore sug-
gested for use in the LiST model for malaria preven-
tion during the first two pregnancies with either IPTp
or ITNs for preventing LBW (Box 2).
Discussion
We performed a systematic review of the published
and unpublished literature to quantify the best esti-
mate for the PE of ITNs and IRS for preventing mor-
tality due directly to malaria in children 1–59 months,
and the effect of ITNs and IPTp on preventing neona-
tal and child deaths through improvements in birth
outcomes, in P. falciparum endemic settings. Results
will be used for the default settings of PE in the
LiST model for estimating the number of child
malaria deaths that can be prevented from scale-up
of these malaria prevention interventions.
Box 1 Cause-specific mortality effect and quality grade of the estimate for the effect of ITNs and IRS
Cause specific mortality to act on:
Malaria-attributable mortality among children 1–59 months.
Cause-specific effect and range:
55% (49–60%)
Quality of input evidence:
Moderate (three high-quality community-randomized controlled trials assessing ITNs on the reduction of
ACCM 1–59 months).
These data are supported by data on the reduction of uncomplicated malaria incidence obtained from
high-quality community-randomized controlled trials,
21–24 as well as by cross-sectional studies assessing
changes in the prevalence of malaria parasite infections under programme conditions.
60
Proximity of the data to cause specific mortality effect:
Moderate (all-cause mortality 1–59 months).
Limitations of the evidence:
There were no randomized controlled trials on the impact of IRS. The PE for malaria-specific mortality 1–59
months had to be derived from ACCM with data on the proportion of all child deaths due to malaria coming
from post-mortem verbal autopsies with known limitations.
10,12,61
Total search results = 177
Studies remaining after screening title and 
abstract = 31
7 studies included for data abstraction (all 
before-after studies)
All-cause infant or 
child mortality = 3
Incidence of 
uncomplicated malaria = 3
Prevalence of malaria 
parasitemia = 5
24 studies excluded due 
to lack of isolation of 
IRS from other 
interventions, or did not 
assess an appropriate 
child health outcome in
P. falciparum endemic 
setting
Figure 3 Results of systematic review on the effect of IRS on child health outcomes
i94 INTERNATIONAL JOURNAL OF EPIDEMIOLOGYBased on the meta-analysis-derived PE of ITNs on
ACCM 1–59 months of 18%, we estimate the PE of
ITNs and IRS on reducing malaria-attributable
mortality 1–59 months to be 55%, with a range of
49–61%. We surmise this may be a slight underesti-
mate of the true impact of ITNs on reducing child mor-
tality because the impact of ITNs ascertained by the
trials were likely biased towards the null from the ben-
eficial effect of ITNs to unprotected children in control
villages as a result of their community effect.
44
Two community-randomized controlled trials
attempted to assess the impact of ITNs on
malaria-attributable mortality.
8,9 The trial from the
Gambia showed a non-significant PE against child
deaths due to malaria of 14%, while the trial from
Ghana showed a non-significant reduction in PE of
22% against this outcome. These results are lower
than expected and stand in contradiction to the trial
results for the PE against ACCM of 23 and 18%,
respectively, as well as compared with the results of
this meta-analysis of an 18% PE of ITNs against
ACCM. In light of these contradictions, we surmise
error due to misclassification, which likely resulted
in bias as well as increased variance about point esti-
mates,
10–12 limits the validity of these estimates from
the Gambia and Ghana.
We used two methods to derive the PE of ITNs on
malaria-attributable mortality based on their observed
effect on ACCM. We surmise the first approach result-
ing in a PE of 60% yields the most robust estimate
because the proportion of all deaths due to malaria
was estimated across 31 studies within 14 countries
with P. falciparum transmission between 1980 and
2000, thus it is likely less sensitive to systematic
errors in post-mortem verbal autopsies as compared
with the second method which was estimated across
only three study sites in three countries.
We propose that the default coverage indicator for
ITN and IRS in the LiST model use a composite indi-
cator for the proportion of households protected by
either intervention established from the following
two indicators: the proportion of households with
51 ITN, and the proportion of households sprayed
by IRS in the past 12 months.
45 We suggest that
ITN household possession be used instead of ITN
use by children <5 for the following reasons. First,
the trials from which the meta-analysis-derived 18%
PE of ITNs on reducing ACCM 1–59 months were all
based on intention-to-treat analyses, meaning the
estimated RRs were based on whether or not a child
lived in a village that was given ITNs or not; while use
was measured separately within intervention villages,
it never entered into the RR estimates. Second, ITN
household possession captures the community effect
of ITNs better than individual use. Third, ITN use
among children ascertained by household surveys
such as the Demographic and Health Survey and
the Unicef Multiple Indicator Cluster Survey, which
are implemented during the dry season, yield
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PREVENTION OF MALARIA IN ENDEMIC AREAS i95underestimates of use during higher transmission sea-
sons.
46–49 Fourth, use last night, as measured by
household surveys, is likely the lowest measure of
regular use over time. And last, use by a child
under five likely underestimates use by anyone in
the house, which is important vis-a `-vis the ‘bait and
kill’ effect that ITNs provide for reducing the overall
abundance of Anopheles mosquitoes.
Our meta-analysis shows the PE of malaria preven-
tion interventions in pregnancy (IPTp or ITNs) to
have a pooled PE of 35% (95% CI: 23–45%) on redu-
cing the prevalence of LBW in the first two pregnan-
cies within areas of stable P. falciparum transmission.
LBW has been shown to be associated with marked
increases in neonatal and infant mortality.
50–52 While
LBW is due to either IUGR or pre-term delivery, the
effect of malaria prevention interventions during
pregnancy on LBW in the LiST model acts solely
through IUGR with a 35% PE. Using IUGR as a
proxy for LBW seems reasonable as it has been
shown that IUGR is the predominant cause of LBW
in settings of high malaria transmission.
53,54 The
effect of IUGR has two effects in the LiST model as
noted elsewhere.
30 First, children with IUGR have
a greater RR of dying during the neonatal period,
with increased RR of dying due to diarrhoea
(RR¼2.0), sepsis/pneumonia (RR¼2.0) and asphyxia
(RR¼2.3). Second, IUGR increases the chance that
the child will be stunted, which in turn increases
the RR for measles, malaria, diarrhoea and pneumo-
nia deaths by ages in the post-neonatal period.
It should be noted that that malaria prevention
during pregnancy shows a significant protective
effect against perinatal mortality when two trials on
regular prophylaxis are included in the analysis
[RR¼0.73 (95% CI¼0.53–0.99)].
14 One trial in the
Gambia evaluated weekly pyrimethamine-dapsone
provision
55 while the other in Uganda assessed
weekly chloroquine provision.
56 However, we have
chosen to omit these studies from the LiST model as
continuous daily or weekly provision of antimalarials
does not fit the definition of IPTp that is being imple-
mented across stable P. falciparum malaria settings in
sub-Saharan Africa.
Data from two randomized controlled trials show
IPTp reduces neonatal mortality by 38% among
women in the first or second pregnancy [RR¼0.62
(95% CI: 0.37–1.05)]; this result was not statistically
significant as neither trial was powered to assess this
outcome.
39,40 This is supported by estimates that sug-
gest LBW from malaria in pregnancy in areas of stable
transmission account for as much as 11% of neonatal
deaths and 6% of all infant deaths.
52 Additionally,
maternal malaria has been shown to be associated
with increased risk of prematurity specifically, which
has been shown to be associated with increased neo-
natal and early infant mortality.
57–59 If this effect of
IPTp/ITNs can be better quantified with additional
data, from additional analyses of conducted rando-
mized controlled trials or from observational data,
its effect during pregnancy for reducing neonatal
and infant mortality directly should be used in the
LiST model instead of acting indirectly through
IUGR. Until then, the effect of IPTp and ITNs on
neonatal and early infant mortality, estimated
through IUGR, will likely be underestimated in the
LiST model.
We propose that the default coverage indicator in
the LiST model for IPTp and ITNs used in pregnancy
be comprised of a composite indicator for the propor-
tion of pregnant women protected by either interven-
tion established from the following two indicators:
the proportion of women who received IPTp during
antenatal care visits during their last pregnancy, and
the proportion of pregnant women who slept under
an ITN the previous night.
45 In the LiST model for
IPTp, the coverage indicator applies only to women
in their first or second pregnancy in countries with
stable P. falciparum transmission where IPTp is
national policy. While the indicators for IPTp and
ITNs are not contemporaneous, they are readily avail-
able from most national household surveys and
Total search results = 32
2006 Cochrane and 2007 JAMA Reviews = 4
Post Cochran = 28
Studies remaining after screening title and 
abstract = 10
4 studies included for data abstraction (all
randomized controlled trials; all in 2006 or
2007 Cochrane Reviews)
Neonatal mortality = 2 Perinatal mortality = 1 Prevalence of LBW = 3
6 studies excluded due to 
lack of appropriate 
control group, could not 
isolate IPTp from ITNs,
or did not assess an 
appropriate child health 
outcome in P. falciparum
endemic setting
Figure 4 Results of systematic review on the effect of IPTp on child health outcomes
i96 INTERNATIONAL JOURNAL OF EPIDEMIOLOGYapproximate coverage of either intervention. However,
the two studies that were used to quantify the effect
of ITNs on birth outcomes used different units of ran-
domization which has implications for selecting the
appropriate coverage indicator for LiST.
41,43 Njagi
and colleagues (2002) randomized individual preg-
nant women to receive ITNs, which is much closer
to assessing the individual effect of ITN use, while
ter Kuile and colleagues (2003) randomized commu-
nities and thus their estimated PE is a result of
whether or not a pregnant woman lived in a village
with high ITN household possession. Thus, there is no
perfect indicator of ITN coverage that matches both
studies. For this reason, we have chosen to recom-
mend ITN use (personal protection) over ITN house-
hold possession in the LiST model for assessing the
impact of ITNs/IPTp on reducing LBW to be most con-
servative (i.e. ITN use is always lower than ITN
household possession).
There are several limitations of using the LiST model
to estimate the number of child malaria deaths that
could be prevented through scale-up of prevention
intervention coverage. First, the PE of ITNs and IRS
is assumed constant across intervention coverage.
Based on previous observations from the ITN trials,
it is likely that the true protective effect of vector
control interventions increases with increasing cover-
age due to a community effect, which at this point is
unaccounted for in the LiST model.
44 Second, the LiST
model does not currently account for the PE of ITN/
IRS scale-up on indirect malaria mortality where
malaria is eliminated as a coinfection that contributes
to a child death. This likely results in a significant
underestimation of the true number of child deaths
that could be prevented from malaria prevention inter-
vention scale-up. Third, the coverage of interventions
in the LiST model are assumed independent, while in
reality it is likely people exposed to one malaria inter-
vention are more likely to be exposed to other malaria
interventions as a result of access to health care issues,
resulting in an overestimate of impact. And last, the
LiST model does not account for any possible synergis-
tic effect between ITNs and IRS for preventing child
malaria deaths. If data become available that show
any such effects, the LiST model should account for
this dimension on PE.
Unfortunately, birth and death registries are gener-
ally not available in most malaria-endemic countries
for ascertaining changes in malaria-specific mortality.
Until such data become available, the LiST model
should be used to estimate the likely impact that is
occurring across countries vis-a `-vis prevention of
child malaria deaths from intervention coverage
scale-up. Additionally, there are now several rounds
of population-based household surveys, such as the
Demographic and Health Survey and the Multiple
Indicator Cluster Survey, that allow the measurement
of child survival intervention coverage and ACCM
at two or more time points. As a result, the usefulness
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PREVENTION OF MALARIA IN ENDEMIC AREAS i97of the LiST model could potentially be gauged from
comparison with empirical data on time trends in
ACCM and intervention coverage from these surveys.
An additional systematic review focused on quan-
tifying the PE of additional malaria interventions
against child mortality that will be included in the
LiST model is planned, including case management
of uncomplicated and severe malaria and intermittent
preventive therapy in infants. Additionally, future
versions of the LiST model will include interventions
that prevent miscarriage and stillbirths. As there is
evidence that access to ITNs in the first or second
pregnancy in areas of stable P. falciparum transmission
prevents fetal loss (RR¼0.67, 95% CI¼0.47 – 0.97),
16
this intervention will be incorporated into future ver-
sions of LiST for estimating this outcome.
Conclusions
This systematic review quantifies the PE of ITNs and
IRS for reducing malaria-attributable mortality, and
Box 2 PE estimate and quality grade of IPTp and ITNs used during pregnancy at reducing LBW
Cause-specific outcome to act on:
LBW among first or second pregnancies.
Cause-specific effect and range:
35% (23–45%)
Quality of input evidence:
High (five high-quality randomized controlled trials assessing IPTp (3) and ITNs (2) on the reduction of
LBW among a woman’s first two pregnancies).
Proximity of the data to cause-specific mortality effect:
Moderate (LBW in the LiST model acts through IUGR as a risk factor for neonatal and post-neonatal child
mortality). However, there is robust evidence that LBW, due to IUGR and prematurity, increases the risk of
neonatal and early infant mortality.
50–52,59
Limitations of the evidence:
Ideally, the impact of IPTp and ITNs in pregnancy could be quantified on the outcome of neonatal and/or
infant mortality. However, as of yet the pooled estimate for IPTp and ITNs for reducing neonatal mortality is
no statistically significant as the trials were not powered to detect slight changes in this outcome. As data
become available it will be important to quantify the effect of malaria prevention interventions during
pregnancy on neonatal and child mortality.
RR (95% CI) 
Parise (1998) / IPTp 
Njagi (2002) / IPTp 
Njagi (2002) / ITN 
Overall (I
2 = 0%) 
0.54 (0.35 - 0.84) 
0.70 (0.42 – 1.18) 
0.68 (0.41 – 1.13) 
0.65 (0.55 - 0.77) 
  33.2 
  13.0 
  11.5 
100.0
1 .1
Relative Risk (95% Confidence Interval) 
Heterogeneity X
2 = 2.14 (d.f = 4); P-value = 0.710 
I
2 (variance RR attributable to heterogeneity) = 0% 
Test for RR= 1; Z = 4.92; P-value < 0.001  
Ter Kuile (2003) / ITN 
Challis (2004) / IPTp 
0.72 (0.53 - 0.98) 
0.71 (0.41 – 1.24) 
  31.7 
  10.6 
Study (date) / intervention  Weight (%)
10
Figure 5 Forest plot for the meta-analysis of the effect of IPTp and ITNs used during first or second pregnancy for reducing
LBW vs no IPTp (placebo) or ITNs
i98 INTERNATIONAL JOURNAL OF EPIDEMIOLOGYthe PE of IPTp and ITNs during pregnancy for redu-
cing LBW. These data support the continued scale-up
of these malaria prevention interventions in endemic
settings that will prevent a considerable number of
child deaths due directly and indirectly to malaria.
These PE estimates will allow the use of the LiST
model for estimating the likely impact of past inter-
vention scale-up, as well as for predicating future
impact of intervention scale-up by national malaria
control programmes.
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Supplementary data are available at IJE online.
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KEY MESSAGES
  We estimate the protective efficacy of insecticide-treated mosquito nets and indoor-residual spraying
on reducing malaria-attributable mortality 1–59 months to be 55%, with a range of 49–61%, in
Plasmodium falciparum settings.
  We estimate malaria prevention interventions in pregnancy (intermittent preventive therapy and
insecticide-treated mosquito nets) to have a pooled protective efficacy of 35% (95% confidence inter-
val: 23–45%) on reducing the prevalence of low birth weight in the first or second pregnancy in areas
of stable Plasmodium falciparum transmission.
  These data support the continued scale-up of these malaria prevention interventions in endemic
settings that will prevent a considerable number of child deaths due directly and indirectly to
malaria.
  These protective efficacy estimates will allow the use of the LiST model for estimating the likely
impact of past intervention scale-up, as well as for predicating future impact of intervention scale-up
by national malaria control programs.
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